The Application of ATR Kinase Inhibitor AZD۶۷۳۸ in Combination with Radiotherapy for the Treatment of Melanoma

سال انتشار: 1401
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 43

فایل این مقاله در 10 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_JBPE-12-3_006

تاریخ نمایه سازی: 30 دی 1402

چکیده مقاله:

Background: Melanoma is categorized as one of the most malignant, severe, and lethal cancers of the skin. Regarding the lack of efficiency of conventional therapies for most patients, novel therapeutic strategies are strongly required. Objective: The current study aimed to assess the impact of AZD۶۷۳۸- an ATR kinase inhibitor- in combination with ۶ MV X-ray on the human melanoma cell line (A۳۷۵).Material and Methods: In this experimental study, cells were treated with different concentrations of AZD۶۷۳۸ for ۲۴ and ۴۸ h in the presence and absence of radiation (۲ Gy, ۴ Gy, and ۶ Gy). The cell viability and cell proliferation assay were examined in both experimental and control groups by MTT and colony formation techniques, respectively. Results: The results indicated that by increasing the concentration of AZD۶۷۳۸, the cell viability was markedly diminished in all treatment groups. As expected, the cell viability of the cells treated with AZD۶۷۳۸ and radiation was significantly lower than the group treated with AZD۶۷۳۸ alone. Besides, the combinatory treatment significantly decreased cell proliferation in the melanoma cell line. The combination of AZD۶۷۳۸ with radiation resulted in a significant increase in cytotoxicity by a ۵۰% increase in cell death when used at concentrations of ۰.۳ µM, ۱ µM, ۱.۵۱ µM, and ۱.۶۱ µM, respectively. Conclusion: The combination of AZD۶۷۳۸ with radiation possesses a synergistic effect on the reduction of the cell viability and proliferation of melanoma cells. This present study provides insight into the impact of Ataxia Telangiectasia and Rad۳-related kinase (ATR) inhibition on the potential role of this kinase in the suppression of melanoma cell proliferation.

نویسندگان

- -

MSc, Radiation Biology Research Center, Iran University of Medical Sciences, Tehran, Iran

- -

PhD, Radiation Biology Research Center, Iran University of Medical Sciences, Tehran, Iran

- -

PhD, Radiation Biology Research Center, Iran University of Medical Sciences, Tehran, Iran

- -

MSc, Radiation Biology Research Center, Iran University of Medical Sciences, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Mendenhall WM, Riggs CE, Vaysberg M, Amdur RJ, Werning JW. ...
  • Thayaparasingham B, Kunz A, Peters N, Kulms D. Sensitization of ...
  • Lasithiotakis KG, Leiter U, Gorkievicz R, Eigentler T, et al. ...
  • Jahng AW, Liao SS. Successful palliation with octreotide of a ...
  • Chen W, Lu Y, Wu J, Gao M, Wang A, ...
  • De Almodovar JR, Nunez MI, McMillan TJ, Olea N, et ...
  • Khan MK, Khan N, Almasan A, Macklis R. Future of ...
  • Grossmann KF, Margolin K. Long-term survival as a treatment benchmark ...
  • Balavandi Z, Neshasteh-Riz A, Koosha F, et al. The Use ...
  • Gilbert J, Forastiere AA. Organ preservation trials for laryngeal cancer. ...
  • Kumala S, Niemiec P, Wideł M, Hancock R, Rzeszowska-Wolny J. ...
  • Morton DL, Wen DR, Wong JH, Economou JS, et al. ...
  • Garbe C, Hauschild A, Volkenandt M, Schadendorf D, et al. ...
  • Gershenwald JE, Thompson W, Mansfield PF, Lee JE, et al. ...
  • Morton DL, Thompson JF, Cochran AJ, Mozzillo N, et al. ...
  • Garbe C, Terheyden P, Keilholz U, Kölbl O, Hauschild A. ...
  • Gaudi S, Messina JL. Molecular bases of cutaneous and uveal ...
  • Shi H, Liu L, Liu L, Geng J, Zhou Y, ...
  • Ghazikhanlou-Sani K, Rahimi A, Poorkaveh M, et al. Evaluation of ...
  • Karnitz LM, Zou L. Molecular pathways: targeting ATR in cancer ...
  • Brown EJ, Baltimore D. ATR disruption leads to chromosomal fragmentation ...
  • Takai H, Tominaga K, Motoyama N, Minamishima YA, et al. ...
  • Zou L, Elledge SJ. Sensing DNA damage through ATRIP recognition ...
  • Ruzankina Y, Pinzon-Guzman C, Asare A, Ong T, Pontano L, ...
  • Eykelenboom JK, Harte EC, Canavan L, Pastor-Peidro A, et al. ...
  • Kim HJ, Min A, Im SA, Jang H, Lee KH, ...
  • Pires IM, Olcina MM, Anbalagan S, Pollard JR, et al. ...
  • Hammond EM, Denko NC, Dorie MJ, Abraham RT, Giaccia AJ. ...
  • Hammond EM, Dorie MJ, Giaccia AJ. Inhibition of ATR leads ...
  • Zhou ZW, Liu C, Li TL, Bruhn C, Krueger A, ...
  • Demidenko ZN, Blagosklonny MV. Flavopiridol induces p۵۳ via initial inhibition ...
  • Murga M, Campaner S, Lopez-Contreras AJ, Toledo LI, et al. ...
  • Dillon MT, Barker HE, Pedersen M, Hafsi H, Bhide SA, ...
  • Foote KM, Lau A, M Nissink JW. Drugging ATR: progress ...
  • Checkley S, MacCallum L, Yates J, Jasper P, Luo H, ...
  • Vendetti FP, Lau A, Schamus S, Conrads TP, O’Connor MJ, ...
  • Clack G, Lau A, Pierce A, Smith S, Stephens C. ...
  • Min A, Im SA, Jang H, Kim S, Lee M, ...
  • نمایش کامل مراجع